CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.

@article{Ohshima2001CD10AB,
  title={CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.},
  author={Koichi Ohshima and Chika Kawasaki and Hiromi Muta and Koichiro Muta and Vadim V. Deyev and Seiji Haraoka and Junji Suzumiya and Eckhard R. Podack and Masahiro Kikuchi},
  journal={Histopathology},
  year={2001},
  volume={39 2},
  pages={156-62}
}
AIMS Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically and pathologically heterogeneous. The Bcl10 gene was recently isolated from the breakpoint region of t(1;14)(p22;q32) in mucosa-associated lymphoid tissue (MALT) lymphomas, and is considered to be an apoptosis-associated gene. CD10 is considered to be a marker of follicular centre B-cell differentiation. To assess the clinical significance and roles of CD10 and Bcl10 in DLBCL, we… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

Similar Papers

Loading similar papers…